The first patient to receive a breakthrough treatment on the NHS for his aggressive form of leukaemia has said it was ...

A Las Vegas hospital has achieved a major milestone as staff celebrates the completion of its 100th stem cell transplant. The ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...

Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after treatment. Traditional treatments like chemotherapy, radiation, and even ...

Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does it mean for investors?